Lv11
70 积分 2025-04-07 加入
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
3小时前
待确认
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
13天前
已完结
Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges
15天前
已完结
Rapid Advances in Resectable Non–Small Cell Lung Cancer
15天前
已完结
Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive review
15天前
已完结
Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
15天前
已完结
The landscape of cancer research and cancer care in China
21天前
已完结
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
25天前
已完结
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
28天前
已完结
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice
29天前
已完结
皖公网安备34019202002308
